盆腔器官脱垂修复时尿道填充术与中段尿道吊带术的并发症和再治疗比较
这项回顾性队列研究利用Premier医疗数据库2001至2018年数据,比较盆腔器官脱垂修复同期行尿道填充术(540例)与中段尿道吊带术(91,005例)患者的再治疗率和并发症。尿道填充术2年内再次抗尿失禁手术率高于吊带术(9.07% vs 1.11%,P<.001),调整混杂因素后吊带术与2年再手术几率降低相关(aOR 0.11,95%CI 0.08-0.16),且尿道填充术2年并发症概率更高(23.0% vs 15.0%,P<.001)。
要点
- 盆腔器官脱垂修复同期行尿道填充术者2年内再次抗尿失禁手术率为9.07%,高于中段尿道吊带术的1.11%(P<.001)。
- 调整混杂因素后,中段尿道吊带术与2年再次抗尿失禁手术几率降低相关(aOR 0.11,95%CI 0.08-0.16)。
- 尿道填充术2年内任何并发症概率为23.0%,高于中段尿道吊带术的15.0%(P<.001)。
核心结论
- 盆腔器官脱垂修复同期行尿道填充术与术后2年内更高的再次手术率和术后并发症率相关。
研究设计与样本
- 回顾性队列研究,使用Premier医疗数据库数据。
- 通过现行操作术语代码识别2001至2018年间行盆腔器官脱垂修复同期尿道填充术或中段尿道吊带术的患者。
- 排除同期行非妇科手术、Burch尿道固定术或肿瘤手术者,以及未同时行盆腔器官脱垂和抗尿失禁手术者。
- 收集患者人口学特征、医院特征、外科医生手术量和合并症数据。
- 主要结局为2年内再次抗尿失禁手术,次要结局为复合并发症率。
主要发现
- 研究期间540例(0.59%)行尿道填充术,91,005例(99.41%)行中段尿道吊带术。
- 尿道填充术组2年内再次手术率为9.07%,高于中段尿道吊带术组的1.11%(P<.001)。
- 尿道填充术组中4.81%再次行尿道填充术,4.81%行中段尿道吊带术。
- 中段尿道吊带术组中0.77%再次行中段尿道吊带术,0.36%行尿道填充术。
- 调整混杂因素后,中段尿道吊带术与2年再次抗尿失禁手术几率降低相关(aOR 0.11,95%CI 0.08-0.16)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare postprocedure retreatment rates for stress incontinence in patients who underwent either midurethral sling or urethral bulking at the time of concomitant repair of pelvic organ prolapse (POP). METHODS: This was a retrospective cohort study using data from the Premier Healthcare Database. Using Current Procedural Terminology codes, we identified patients who were undergoing POP repair and concomitant urethral bulking or midurethral sling between the years 2001 and 2018. Patients who underwent concomitant nongynecologic surgery, Burch urethropexy, or oncologic surgery, and those who did not undergo concomitant POP and anti-incontinence surgery, were excluded. Additional data collected included patient demographics, hospital characteristics, surgeon volume, and comorbidities. The primary outcome was a repeat anti-incontinence procedure at 2 years, and the secondary outcome was the composite complication rate. RESULTS: Over the study period, 540 (0.59%) patients underwent urethral bulking, and 91,005 (99.41%) patients underwent midurethral sling. The rate of a second procedure within 2 years was higher for urethral bulking, compared with midurethral sling (9.07% vs 1.11%, P <.001); in the urethral bulking group, 4.81% underwent repeat urethral bulking and 4.81% underwent midurethral sling. In the midurethral sling group, 0.77% underwent repeat midurethral sling and 0.36% underwent urethral bulking. After adjusting for confounders, midurethral sling was associated with a decreased odds of a repeat anti-incontinence procedure at 2 years (adjusted odds ratio 0.11, 95% CI 0.08-0.16). The probability of any complication at 2 years was higher with urethral bulking (23.0% vs 15.0%, P <.001). CONCLUSION: Urethral bulking at the time of POP repair is associated with a higher rate of repeat procedure and postoperative morbidity up to 2 years after surgery.
引用
- Russell R, Rhodes S, Gupta A, et al. Comparison of Morbidity and Retreatment After Urethral Bulking or Midurethral Sling at the Time of Pelvic Organ Prolapse Repair. Obstet Gynecol. 2023. PMID: 37917942. doi:10.1097/AOG.0000000000005427
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。